123 related articles for article (PubMed ID: 8548018)
1. Automated high-performance liquid chromatographic method for the determination of a neuraminidase inhibitor (GG167) in human serum by pre-column fluorescence derivatisation using benzoin.
Stubbs RJ; Harker AJ
J Chromatogr B Biomed Appl; 1995 Aug; 670(2):279-85. PubMed ID: 8548018
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatographic-tandem mass spectrometric method for the determination of the neuraminidase inhibitor zanamivir (GG167) in human serum.
Allen GD; Brookes ST; Barrow A; Dunn JA; Grosse CM
J Chromatogr B Biomed Sci Appl; 1999 Sep; 732(2):383-93. PubMed ID: 10517361
[TBL] [Abstract][Full Text] [Related]
3. Determination of the novel sialic acid analog GG167 (GR121167X) in human urine by liquid chromatography: direct injection with column switching.
Morris DM; Hussey BK; Geurin SL; Selinger KA
J Pharm Biomed Anal; 1995 Dec; 14(1-2):191-201. PubMed ID: 8833982
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK
JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
[TBL] [Abstract][Full Text] [Related]
6. High-performance liquid chromatographic assay for 2'-deoxy-3'-thiacytidine in human serum.
Harker AJ; Evans GL; Hawley AE; Morris DM
J Chromatogr B Biomed Appl; 1994 Jul; 657(1):227-32. PubMed ID: 7952073
[TBL] [Abstract][Full Text] [Related]
7. High-performance liquid chromatographic determination of GS4071, a potent inhibitor of influenza neuraminidase, in plasma by precolumn fluorescence derivatization with naphthalenedialdehyde.
Eisenberg EJ; Cundy KC
J Chromatogr B Biomed Sci Appl; 1998 Sep; 716(1-2):267-73. PubMed ID: 9824240
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic measurement of guanidino compounds of clinical importance in human urine and serum by pre-column fluorescence derivatization using benzoin.
Kai M; Miyazaki T; Ohkura Y
J Chromatogr; 1984 Nov; 311(2):257-66. PubMed ID: 6520173
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 4-azido-4-deoxy-Neu5,7,8,9Ac42en1Me. A key intermediate for the synthesis of GG167 from D-glucono-delta-lactone.
Liu KG; Yan S; Wu YL; Yao ZJ
Org Lett; 2004 Jun; 6(13):2269-72. PubMed ID: 15200337
[TBL] [Abstract][Full Text] [Related]
11. High-performance liquid chromatographic method for monitoring leupeptin in mouse serum and muscle by pre-column fluorescence derivatization with benzoin.
Kai M; Miura T; Ishida J; Ohkura Y
J Chromatogr; 1985 Dec; 345(2):259-65. PubMed ID: 4086597
[TBL] [Abstract][Full Text] [Related]
12. Consideration of use of neuraminidase inhibitors such as oseltamivir and zanamivir in IgA nephropathy.
Altschuler EL; Bhatia A; Kast RE
Kidney Int; 2005 Dec; 68(6):2910-1. PubMed ID: 16316376
[No Abstract] [Full Text] [Related]
13. Does the availability of a neuraminidase inhibitor impair influenza vaccination? A report from Austria.
Kunze U; Groman E; Vymazal K; Hartl HK
Vaccine; 2001 Feb; 19(15-16):1854. PubMed ID: 11345055
[No Abstract] [Full Text] [Related]
14. Development of a sensitive chemiluminescent neuraminidase assay for the determination of influenza virus susceptibility to zanamivir.
Buxton RC; Edwards B; Juo RR; Voyta JC; Tisdale M; Bethell RC
Anal Biochem; 2000 May; 280(2):291-300. PubMed ID: 10790313
[TBL] [Abstract][Full Text] [Related]
15. [Neuraminidase inhibitors against influenza].
Med Monatsschr Pharm; 1999 Sep; 22(9):262-4. PubMed ID: 10536414
[No Abstract] [Full Text] [Related]
16. Treating influenza with zanamivir.
Read RC
Lancet; 1998 Dec; 352(9144):1872-3. PubMed ID: 9863779
[No Abstract] [Full Text] [Related]
17. Automated sample clean-up with solid-phase extraction for the determination of aflatoxins in urine by liquid chromatography.
Kussak A; Andersson B; Andersson K
J Chromatogr; 1993 Jul; 616(2):235-41. PubMed ID: 8376505
[TBL] [Abstract][Full Text] [Related]
18. Neuraminidase inhibitors and relief of influenza symptoms.
Lemon M; Meade F
S D J Med; 2000 Mar; 53(3):99-100. PubMed ID: 10745653
[No Abstract] [Full Text] [Related]
19. New approaches to influenza chemotherapy. Neuraminidase inhibitors.
Calfee DP; Hayden FG
Drugs; 1998 Oct; 56(4):537-53. PubMed ID: 9806102
[TBL] [Abstract][Full Text] [Related]
20. A side effect of neuraminidase inhibitor in a patient with liver cirrhosis.
Kaji M; Fukuda T; Tanaka M; Aizawa H
J Infect Chemother; 2005 Feb; 11(1):41-3. PubMed ID: 15729487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
